secwatch.observer — SEC 8-K summary
======================================

Issuer:     ANAPTYSBIO, INC (ANAB)
CIK:        0001370053
Form:       8-K
Filed at:   2021-11-29T23:59:59+00:00
Accession:  0001370053-21-000075
Event type: leadership
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Appoints Daniel Faga as Class I director effective Nov 26, 2021
---------------------------------------------------------------

- Daniel Faga appointed to board as Class I director, effective immediately on Nov 26, 2021.
- Received option for 2,321 shares at closing price on appointment date, vesting fully on Feb 10, 2022.
- Also granted option for 11,000 shares at same exercise price, vesting monthly over three years.
- Company entered into standard indemnification agreement with Faga.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1370053/000137005321000075/0001370053-21-000075-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1370053/000137005321000075/anab-20211126.htm
  HTML page:      https://secwatch.observer/filing/0001370053-21-000075

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer